SS Innovations International Inc. Common Stock

Healthcare US SSII

3.36USD
-0.17(4.82%)

Last update at 2026-06-12T20:00:00Z

Day Range

3.243.62

LowHigh

52 Week Range

3.6318.00

LowHigh

Fundamentals

Previous Close 3.53
Market Cap1315.55M
Volume40659
P/E Ratio-
Dividend Yield-%
EBITDA-5.38175M
Revenue TTM4.54M
Revenue Per Share TTM0.15
Gross Profit TTM 0.00000M
Diluted EPS TTM-0.52

Overview
Financials
Peer Comparison
Reports
Stock Research & News

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

SS Innovations Reports First Quarter 2025 Financial Results
Wed 14 May 25, 08:32 PM
SS Innovations Announces Chief Financial Officer Transition
Fri 02 May 25, 12:30 PM
SS Innovations Achieves Significant Milestones in 2024
Mon 31 Mar 25, 12:30 PM
SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine
Fri 28 Mar 25, 12:30 PM
SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3
Mon 13 Jan 25, 01:00 PM
SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting
Wed 11 Dec 24, 06:57 PM
SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board
Mon 30 Sep 24, 12:30 PM

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Type	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Income before tax	-2.21301M	-1.48431M	-1.12468M	-3.38597M
Minority interest	-	-	-	-
Net income	-2.21301M	-1.48431M	-1.12468M	-3.38597M
Selling general administrative	2.37M	1.41M	1.10M	3.26M
Selling and marketing expenses	-	-	-	-
Gross profit	-	-	-	-
Reconciled depreciation	0.00914M	0.02M	0.04M	0.04M
Ebit	-	-	-	-
Ebitda	-2.15834M	-1.46553M	-1.08619M	-3.32852M
Depreciation and amortization	-	-	-	-
Non operating income net other	-	-	-	-
Operating income	-2.44761M	-1.40704M	-1.10293M	-3.32268M
Other operating expenses	-	-	-	-
Interest expense	0.05M	0.00000M	0.00106M	0.02M
Tax provision	0.00000M	0.00000M	0.00000M	0.00000M
Interest income	0.00015M	0.00012M	0.00001M	0.00001M
Net interest income	-0.04538M	0.00012M	-0.00105M	-0.01974M
Extraordinary items	-	-	-	-
Non recurring	-	-	-	-
Other items	-	-	-	-
Income tax expense	-	-	-	-
Total revenue	0.00000M	0.00000M	0.00000M	0.00000M
Total operating expenses	2.45M	1.41M	1.10M	3.32M
Cost of revenue	-	-	-	-
Total other income expense net	0.28M	-0.07739M	-0.02070M	-0.04355M
Discontinued operations	-	-	-	-
Net income from continuing ops	-2.21301M	-1.48431M	-1.12468M	-3.38597M
Net income applicable to common shares	-	-	-	-
Preferred stock and other adjustments	-	-	-	-

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Type	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Total assets	4.37M	0.43M	0.32M	0.13M
Intangible assets	-	-	0.00112M	0.01M
Earning assets	-	-	-	-
Other current assets	0.00868M	0.00229M	0.00229M	0.00629M
Total liab	4.05M	0.29M	1.19M	1.20M
Total stockholder equity	0.32M	0.14M	-0.86905M	-1.06326M
Deferred long term liab	-	-	-	-
Other current liab	-	-	-	-
Common stock	-	-	-	-
Capital stock	0.00539M	0.46M	0.10M	0.26M
Retained earnings	-10.69107M	-8.47806M	-6.99375M	-5.86907M
Other liab	-	-	-	-
Good will	-	-	-	-
Other assets	-	-	-	-
Cash	1.35M	0.41M	0.16M	0.03M
Cash and equivalents	-	-	-	-
Total current liabilities	4.05M	0.29M	1.19M	1.20M
Current deferred revenue	-	-	-	-
Net debt	2.65M	-	0.03M	0.43M
Short term debt	-	-	-	-
Short long term debt	4.00M	0.14M	0.20M	0.46M
Short long term debt total	-	-	-	-
Other stockholder equity	-	-	-	-
Property plant equipment	-	-	-	-
Total current assets	4.36M	0.41M	0.16M	0.03M
Long term investments	-	0.00000M	0.12M	-
Net tangible assets	-	-	-	-
Short term investments	-	-	-	-
Net receivables	-	-	-	-
Long term debt	-	-	-	-
Inventory	-	-	-	-
Accounts payable	0.00000M	0.12M	0.13M	0.14M
Total permanent equity	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-
Accumulated other comprehensive income	-	-	-	-
Additional paid in capital	-	-	-	-
Common stock total equity	-	-	-	-
Preferred stock total equity	-	-	-	-
Retained earnings total equity	-	-	-	-
Treasury stock	-	-	-	-
Accumulated amortization	-	-	-	-
Non currrent assets other	-	-	-	-
Deferred long term asset charges	-	-	-	-
Non current assets total	0.01M	0.02M	0.15M	0.10M
Capital lease obligations	-	-	-	-
Long term debt total	-	-	-	-

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Type	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Investments	-3.00000M	0.04M	-0.04400M	-0.05012M
Change to liabilities	-	-	-	-
Total cashflows from investing activities	-	-	-	-
Net borrowings	-	-	-	-
Total cash from financing activities	5.38M	0.57M	0.27M	0.47M
Change to operating activities	-	-	-	-
Net income	-2.21301M	-1.48431M	-1.12468M	-3.38597M
Change in cash	-0.94559M	0.25M	0.13M	-0.00724M
Begin period cash flow	0.41M	0.16M	0.03M	0.04M
End period cash flow	1.35M	0.41M	0.16M	0.03M
Total cash from operating activities	-1.43584M	-0.36303M	-0.09054M	-0.42411M
Issuance of capital stock	1.53M	0.58M	0.19M	0.00000M
Depreciation	0.00914M	0.02M	0.04M	0.04M
Other cashflows from investing activities	-	-	-	-
Dividends paid	-	-	-	-
Change to inventory	-	-	-	-
Change to account receivables	-	-	-	-
Sale purchase of stock	-	-0.02600M	-	-
Other cashflows from financing activities	-	-	-	-
Change to netincome	-	-	-	-
Capital expenditures	0.00000M	0.00000M	0.00400M	0.05M
Change receivables	-	-	-	-
Cash flows other operating	-	-	-	-
Exchange rate changes	-	-	-	-
Cash and cash equivalents changes	-	-	-	-
Change in working capital	-0.09744M	-0.84964M	0.54M	0.37M
Stock based compensation	0.87M	0.77M	0.43M	1.07M
Other non cash items	-0.00000M	1.11M	-	1.42M
Free cash flow	-1.43584M	-0.36303M	-0.09454M	-0.47423M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)
SSII SS Innovations International Inc. Common Stock	-0.17 4.82%	3.36	-	-	-	-
ABT Abbott Laboratories	-1.47 1.64%	88.18	25.97	17.24	3.57	3.20	3.81	16.75
SYK Stryker Corporation	6.56 2.15%	312.20	44.07	24.94	5.51	6.12	6.05	25.73
MDT Medtronic PLC	-0.13 0.16%	80.20	26.60	15.87	3.35	2.08	3.90	14.12
BSX Boston Scientific Corp	-0.26 0.55%	46.91	31.49	17.24	4.41	3.65	4.88	19.19

Reports Covered

View All

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.